Glatiramer acetate depot (extended-release) phase IIa one-year study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (no evidence of disease activity) analysis
2012 ◽
Vol 78
(Meeting Abstracts 1)
◽
pp. PD5.008-PD5.008
2008 ◽
Vol 266
(1-2)
◽
pp. 44-50
◽
2011 ◽
Vol 10
(4)
◽
pp. 329-337
◽
2016 ◽
Vol 15
(1)
◽
pp. 35-46
◽